Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- PMID: 20016504
- DOI: 10.1038/ni.1818
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
Abstract
Immunological self tolerance is maintained at least in part by regulatory T (T(reg)) cells that actively and dominantly control potentially hazardous self-reactive T cells in the periphery. Antigens that stimulate self-reactive T cells may also activate natural T(reg) cells, thereby maintaining dominant self tolerance. Conversely, genetic anomalies or environmental agents that specifically or predominantly affect T(reg) cells cause or predispose to autoimmunity. With recent advances in our understanding of T(reg) cell development in the thymus and periphery and the molecular mechanism of T(reg) cell-mediated suppression, new ways of treating immunological diseases by targeting T(reg) cells at the cellular and molecular levels are envisaged.
Similar articles
-
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.Nat Immunol. 2007 Feb;8(2):191-7. doi: 10.1038/ni1428. Epub 2006 Nov 30. Nat Immunol. 2007. PMID: 17136045
-
Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.Cell Immunol. 2019 May;339:41-49. doi: 10.1016/j.cellimm.2018.09.008. Epub 2018 Sep 29. Cell Immunol. 2019. PMID: 30482489 Free PMC article. Review.
-
Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.Nat Rev Drug Discov. 2013 Jan;12(1):51-63. doi: 10.1038/nrd3683. Nat Rev Drug Discov. 2013. PMID: 23274471 Review.
-
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.Curr Opin Immunol. 2008 Dec;20(6):655-62. doi: 10.1016/j.coi.2008.09.006. Epub 2008 Oct 28. Curr Opin Immunol. 2008. PMID: 18926906
-
Role of regulatory T-cells in autoimmunity.Clin Sci (Lond). 2009 Apr;116(8):639-49. doi: 10.1042/CS20080200. Clin Sci (Lond). 2009. PMID: 19275768 Review.
Cited by
-
The divergent outcome of IL-4Rα signalling on Foxp3 T regulatory cells in listeriosis and tuberculosis.Front Immunol. 2024 Oct 17;15:1427055. doi: 10.3389/fimmu.2024.1427055. eCollection 2024. Front Immunol. 2024. PMID: 39483462 Free PMC article.
-
Exogenous IL-33 promotes tumor immunity via macroscopic regulation of ILC2s.Sci Rep. 2024 Oct 30;14(1):26140. doi: 10.1038/s41598-024-77751-6. Sci Rep. 2024. PMID: 39478174 Free PMC article.
-
CAR immunotherapy in autoimmune diseases: promises and challenges.Front Immunol. 2024 Oct 1;15:1461102. doi: 10.3389/fimmu.2024.1461102. eCollection 2024. Front Immunol. 2024. PMID: 39411714 Free PMC article. Review.
-
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.EMBO Rep. 2024 Jun;25(6):2635-2661. doi: 10.1038/s44319-024-00149-y. Epub 2024 May 10. EMBO Rep. 2024. PMID: 38730210 Free PMC article.
-
The impact of regulatory T cells on the graft-versus-leukemia effect.Front Immunol. 2024 Apr 22;15:1339318. doi: 10.3389/fimmu.2024.1339318. eCollection 2024. Front Immunol. 2024. PMID: 38711496 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources